🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The COAPT Post Approval Study is out in JACC Journals today! Real world data on 5000 SMR patients treated with MitraClip at 406 sites showed that it was safe and effective. Free download available at this link for next 50 days: authors.elsevier.com/a/1hnDt2d9GHwW…

More than 4 years ago, we performed the world's 1st EVOQUE TTVR at St. Michael's Hospital. Our patient continues to do well, paving the way for hundreds of patients suffering from tricuspid regurgitation to receive this innovative and lifesaving therapy. unityhealth.to/2023/10/evoque…

Following a pos ad board, FDA just approved renal denervation with the Recor ultrasound energy-based Paradise system. No word yet on the Medtronic radiofrequency energy-based Spyral system which received a neg ad board review. From our recent JACC editorial results looks similar.

DAPAglofazin Safe in AMI pts without DM, important metabolic benefits for these patients AHA Science #AHA23 American Heart Association Dr. Stefan James Presenting: THE WINS are in favor of DAPA

Do you know the stent #edge is not always at the #marker ! PCICaseBot PCRonline 🫀 @APSIC Gruentzig's Ghost MIЯVΛƬ #IC Mamas A. Mamas Dimitri Zappi, M.D. Neisser M jedicath աǟզǟʀ.ǟɦʍɛɖ A.Nazmi Calik Lorenzo Azzalini Salvatore Brugaletta Erik Rafflenbeul Matthias Götberg Sunil V. Rao Rich_cathRT(CI)☢️ A. Fauzi Yahya Jeffrey Wilson, MD

Optimization of valve expansion for TMVR. Degenerated 27mm Magna w sev stenosis, pre-fractured with 28mm 🎈. 29mm S3 implanted, further post-dilated on atrial side to improve expansion. No post gradient, no leak. Paced OTW. Sentinel captured calcific debries. CT neo-LVOT 321.

After mitral valve repair, women have a higher risk for all-cause mortality at lower LVESD and LVESDi and higher EF. We should consider sex-specific thresholds for LVESDi in surgical decision making in patients with severe MR. jacc.org/doi/10.1016/j.…

The use of DOACs after TMVR, compared with VKAs, appears to reduce the risk of bleeding complications and decrease the length of hospital stay for patients, without a significant increase in the risk of thrombotic events. jacc.org/doi/10.1016/j.…

In a large population of up to 1,000 US and European patients with intermediate- and high-risk pulmonary embolism, mechanical thrombectomy using the FlowTriever System was evaluated without a specified comparison group. The study demonstrated a favourable safety profile, with

Lower plasma ferritin levels are linked to an increased risk of heart failure & diastolic dysfunction in older adults, regardless of anemia status. Iron repletion could be key in preventing heart failure. bit.ly/3uZGrAm #JACCHF #HeartFailure #ARIC #Anemia

New insights into #LAAO post-procedural treatment. ✅ Simplified protocols for high-risk bleeding patients? ✅ Outstanding collaborative effort from several Spanish centers. Pablo Antunez Muiños Rodrigo Estévez Xavier Freixa Ignacio J. Amat ACI-SEC: Hemodinamica S. Cardio. Salamanca @Serlotes

The #EAPCI Core Curriculum for Percutaneous Valvular & Structural Heart Intervention Published in EuroIntervention on the occasion of #ESCCongress 2024 Significant work from the #EAPCI Training & Certification Committee and collaborators. bit.ly/3XowWGh

Not every #TMVR requires contrast CT. #JACCIMG novel approach to neo-LVOT assessment by #echofirst pre-TMVR TEE: neo-LVOT area & #LVOT gradients had no significant bias compared to #YesCCT. bit.ly/3XZCQNq RTHahnMD Fabien Praz Joanna Bartkowiak

First prospective study at Johns Hopkins on >1000 pts w/ #echofirst and #RHC data to define grades of severity of echo-based measures of RV dysfunction in PH population CircImaging bit.ly/4f52fvV Few learning points: ❗️degree of RV dysfx -> worse outcome & symptoms

#TCT2024 Is it time to get rid of cause specific hospitalization as an endpoint? 2 trials showing TAVR reduces CV hosp (EARLY TAVR) and unplanned aortic hospitalization (EVOLVED) with the former hitting a primary composite driving by this cause specific endpoint.

New data for Spanish registry suggesting “the less residual TR, the better” after TTEER. Changing concepts ⁦Ignacio Cruz Gonzalez⁩ ⁦Julio Echarte⁩ ⁦PCRonline 🫀⁩ ⁦ACI-SEC: Hemodinamica⁩ ⁦Manuel Pan⁩ ⁦Belén Cid Alvarez⁩ #TreatTR …ea01.safelinks.protection.outlook.com/?url=https%3A%…

Not so strange!

Great work Julio Echarte and Andrea Scotti. I’m very proud of both you. Thanks for putting a spotlight on the differences in diversity regarding valvular disease. Montefiore Health System Montefiore Health System Albert Einstein College of Medicine - Official Cardiovascular Research Foundation

Il 25 Gennaio 2025 sii terrà presso L'NH Hotel CityLife il primo SINT, meeting cardiologico che promuove il concetto di SINERGISMO tra terapia medica e procedure interventistiche. Vi aspetto instagram.com/p/DD4tq_3oY4c/…

linkedin.com/feed/update/ur…